Biosteon is a synthetic calcium composite technology used for interference screws in the reconstruction of anterior and posterior ligaments and suture anchors for rotator cuff repairs.
- Improved strength retention
- 16 years of proven clinical success
- Over 100,000 implanted worldwide
Biosteon was introduced in 2001 and produced through a proprietary moulding technology, which delivers a suspension of osteoconductive particles of calcium hydroxyapatite in a poly-L-lactic acid (PLLA) matrix – to improve strength retention, bone-bonding potential and pH buffering in the graft healing period. Biosteon has 16 years' proven clinical success and has been implanted in over 100,000 patients worldwide.
The Biosteon Screw features a unique thread form for easy insertion and offers increased pull-out strength compared with similar devices in the market.
The Biosteon Cross Pin is for femoral fixation of soft-tissue (hamstring) grafts.
Biosteon has the longest clinical follow-up of all calcium-based composite materials now entering the market.2 All Biosteon products are distributed exclusively through Stryker.
References: 1. Lind M et al. Knee 2009;16:447–451. 2. Johnston, M., et al., Resorption and remodeling of hydroxyapatite-poly-L-lactic acid composite anterior cruciate ligament interference screws. Arthroscopy, 2011. 27(12): p. 1671-8.
For indications, contraindications, warnings and precautions see Instructions for Use.
©2017, Biocomposites and Biosteon are registered trademarks of Biocomposites Ltd. All rights reserved. No unauthorised copying, reproduction, distributing or re-publication is allowed unless prior written permission is granted by the owner, Biocomposites Ltd.
Patents Granted: EP 1436019 B1, US 8563024, CN ZL02825134.2, EP 1954199 B1, US 8409251